Article (Scientific journals)
Raynaud Phenomenon after Treatment of Verruca Vulgaris of the Sole with Intralesional Injection of Bleomycin
Vanhooteghem, Olivier; Richert, Bertrand; de LA BRASSINNE, Michel
2001In Pediatric Dermatology, 18 (3), p. 249-251
Peer Reviewed verified by ORBi
 

Files


Full Text
Raynaud phenomenon after treatment of verruca vulgaris of the sole with intralesional injection of bleomycin.pdf
Publisher postprint (1.15 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Raynaud; phenomenon; verruca vulgaris; sole; intralesional injection; bleomycin
Abstract :
[en] Intralesional injection of bleomycin (BLM) for the treatment of warts resistant to all conventional therapies is of certain interest because of the drug's low toxicity and its efficacy. However, delayed side effects may appear, particularly Raynaud phenomenon. Accordingly, some precautions must be taken in patients with vascular or collagen diseases and, as a precaution, pregnant or lactating women and infants should not be treated with this drug.
Disciplines :
Dermatology
Author, co-author :
Vanhooteghem, Olivier ;  Université de Liège - ULiège > Dermatologie
Richert, Bertrand ;  Université de Liège - ULiège > Dermatologie
de LA BRASSINNE, Michel ;  Université de Liège - ULiège > Dermatologie
Language :
English
Title :
Raynaud Phenomenon after Treatment of Verruca Vulgaris of the Sole with Intralesional Injection of Bleomycin
Publication date :
May 2001
Journal title :
Pediatric Dermatology
ISSN :
0736-8046
eISSN :
1525-1470
Publisher :
Blackwell Publishing, Malden, United States - Massachusetts
Volume :
18
Issue :
3
Pages :
249-251
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 09 March 2011

Statistics


Number of views
79 (0 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
22
Scopus citations®
without self-citations
21
OpenCitations
 
21

Bibliography


Similar publications



Contact ORBi